238 related articles for article (PubMed ID: 32745807)
1. An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene.
Roubroeks JAY; Smith AR; Smith RG; Pishva E; Ibrahim Z; Sattlecker M; Hannon EJ; Kłoszewska I; Mecocci P; Soininen H; Tsolaki M; Vellas B; Wahlund LO; Aarsland D; Proitsi P; Hodges A; Lovestone S; Newhouse SJ; Dobson RJB; Mill J; van den Hove DLA; Lunnon K
Neurobiol Aging; 2020 Nov; 95():26-45. PubMed ID: 32745807
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
3. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
[TBL] [Abstract][Full Text] [Related]
4. Association of peripheral blood DNA methylation level with Alzheimer's disease progression.
Li QS; Vasanthakumar A; Davis JW; Idler KB; Nho K; Waring JF; Saykin AJ;
Clin Epigenetics; 2021 Oct; 13(1):191. PubMed ID: 34654479
[TBL] [Abstract][Full Text] [Related]
5. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease.
Smith AR; Smith RG; Pishva E; Hannon E; Roubroeks JAY; Burrage J; Troakes C; Al-Sarraj S; Sloan C; Mill J; van den Hove DL; Lunnon K
Clin Epigenetics; 2019 Mar; 11(1):52. PubMed ID: 30898171
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities.
Pathak GA; Silzer TK; Sun J; Zhou Z; Daniel AA; Johnson L; O'Bryant S; Phillips NR; Barber RC
J Alzheimers Dis; 2019; 72(3):733-749. PubMed ID: 31640099
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.
Watson CT; Roussos P; Garg P; Ho DJ; Azam N; Katsel PL; Haroutunian V; Sharp AJ
Genome Med; 2016 Jan; 8(1):5. PubMed ID: 26803900
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
9. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
Soares HD; Potter WZ; Pickering E; Kuhn M; Immermann FW; Shera DM; Ferm M; Dean RA; Simon AJ; Swenson F; Siuciak JA; Kaplow J; Thambisetty M; Zagouras P; Koroshetz WJ; Wan HI; Trojanowski JQ; Shaw LM;
Arch Neurol; 2012 Oct; 69(10):1310-7. PubMed ID: 22801723
[TBL] [Abstract][Full Text] [Related]
10. Dietary intakes and biomarker patterns of folate, vitamin B
An Y; Feng L; Zhang X; Wang Y; Wang Y; Tao L; Qin Z; Xiao R
Clin Epigenetics; 2019 Oct; 11(1):139. PubMed ID: 31601260
[TBL] [Abstract][Full Text] [Related]
11. Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
Kobayashi N; Shinagawa S; Nagata T; Shimada K; Shibata N; Ohnuma T; Kasanuki K; Arai H; Yamada H; Nakayama K; Kondo K
PLoS One; 2016; 11(1):e0146449. PubMed ID: 26742120
[TBL] [Abstract][Full Text] [Related]
12. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
[TBL] [Abstract][Full Text] [Related]
13. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
Johnstone D; Milward EA; Berretta R; Moscato P;
PLoS One; 2012; 7(4):e34341. PubMed ID: 22485168
[TBL] [Abstract][Full Text] [Related]
14. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.
Haertle L; Müller T; Lardenoije R; Maierhofer A; Dittrich M; Riemens RJM; Stora S; Roche M; Leber M; Riedel-Heller S; Wagner M; Scherer M; Ravel A; Mircher C; Cieuta-Walti C; Durand S; van de Hove DLA; Hoffmann P; Ramirez A; Haaf T; El Hajj N; Mégarbané A
Clin Epigenetics; 2019 Dec; 11(1):195. PubMed ID: 31843015
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
16. Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study.
Swaminathan S; Shen L; Kim S; Inlow M; West JD; Faber KM; Foroud T; Mayeux R; Saykin AJ; ;
Curr Alzheimer Res; 2012 Sep; 9(7):801-14. PubMed ID: 22486522
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer's disease and amnesic mild cognitive impairment patients.
Shinagawa S; Kobayashi N; Nagata T; Kusaka A; Yamada H; Kondo K; Nakayama K
Neurosci Lett; 2016 Aug; 629():33-37. PubMed ID: 27356276
[TBL] [Abstract][Full Text] [Related]
19. The APOE Gene is Differentially Methylated in Alzheimer's Disease.
Foraker J; Millard SP; Leong L; Thomson Z; Chen S; Keene CD; Bekris LM; Yu CE
J Alzheimers Dis; 2015; 48(3):745-55. PubMed ID: 26402071
[TBL] [Abstract][Full Text] [Related]
20. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
